Panax spp Root-Derived Ingredients: CIR Safety Assessment Summary
CIR safety assessment summary for Panax spp Root-Derived Ingredients: ingredients reviewed, panel verdict, use concentration context, conditions, and sour.
Panax spp Root-Derived Ingredients appears in a CIR safety assessment covering Panax spp Root-Derived Ingredients. The panel verdict for the report is safe. The CIR Expert Panel concluded that the following ingredients are safe in the present practices of use and concentration described in this safety assessment: Panax ginseng root extract, hydrolyzed ginseng root*, hydrolyzed ginseng root extract*, hydrolyzed ginseng saponins*, Panax ginseng root*, Panax ginseng root powder, Panax ginseng root water*, Panax ginseng root oil*, Panax ginseng root. Becker et al 35S *Not reported to be in use.
| Field | CIR value |
|---|---|
| Primary ingredient | Panax spp Root-Derived Ingredients |
| CIR verdict | safe |
| Report type | Safety Assessment |
| Date | 2015 |
| CAS numbers | 50647-08-0, 90045-38-8 |
| Use concentration context | present practices of use and concentration described in the safety assessment |
| Conditions or carve-outs | The CIR Expert Panel concluded that the following ingredients are safe in the present practices of use and concentration described in this safety assessment: Panax ginseng root extract, hydrolyzed ginseng root*, hydrolyzed ginseng root extract*, hydrolyzed ginseng saponins*, Panax ginseng root*, Panax ginseng root powder, Panax ginseng root water*, Panax ginseng root oil*, Panax ginseng root. |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Panax spp Root-Derived Ingredients.
Safety Conclusion
The conclusion for Panax spp Root-Derived Ingredients should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
For use levels, the report gives this concentration context: present practices of use and concentration described in the safety assessment. That language is the safe-use context shown for this page.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Panax spp Root-Derived Ingredients, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Panax spp Root-Derived Ingredients should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Panax spp Root-Derived Ingredients, with source details retained at the bottom for audit.
Source
- CIR report: Safety Assessment of Panax spp Root-Derived Ingredients as Used in Cosmetics Lillian C. Becker1, Wilma F. Bergfeld2, Donald V. Belsito2, Ronald A. Hill2, Curtis D. Klaassen2, Daniel C. Liebler2,
- CIR source file: PRS592.pdf
- Extraction JSON: Source documentation archived.
- Conclusion page in CIR extraction: 31